Clinical Trial Update: Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating immunogenicity when a Japanese encephalitis vaccine is co-administered with a Measles-Mumps-Rubella vaccine; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis
• Measles
• Mumps
• Rubella

Drugs mentioned

• Japanese Encephalitis Vaccine (Japanese Encephalitis vaccine)
• Measles, Mumps, Rubella vaccine (Measles, Mumps, Rubella vaccine)

Snippet

Sponsor: Liaoning Chengda Biotechnology CO., LTD | Conditions: Japanese Encephalitis, Measles | Phase 4 | Status: COMPLETED